SourcingAI
Try for free
Powered by Made-in-China.com
GMP, High Quality, Manufactor, Diclofenac Tablet
US$0.20
10,000 Pieces
Sample price:US$0.01/pcs.Request sample

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

For oral administration

Model NO.

20mg/50mg/100mg

Suitable for

Adult

State

Solid

Shape

Tablet

Type

Biological Products

Pharmaceutical Technology

Chemical Synthesis

Transport Package

10's/Blister, 50's/Box, 20boxes/Carton

Specification

100mg

Trademark

OEM

Origin

China

HS Code

3004909099

Production Capacity

5000000box

Key features

Manufacturer Direct Supply: Direct from manufacturer with 21 years of export experience and 126 employees.
OEM Service Available: Customization available from samples and designs with own brand options.
100% Finished Product Inspection: Visual and function inspection performed on all finished products before shipping.
Wide Application Scope: Treats rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, and soft tissue injuries.
Global Payment Options: Supports T/T, D/P, PayPal, Western Union, and small-amount payments.
Flexible Incoterms: Offers FOB, CIF, CFR, and EXW terms from Shanghai, Guangzhou, and Ningbo ports.
Traceable Raw Materials: Full traceability system implemented for all raw material inputs.
Consistent Lead Time: One month lead time available for both peak and off-peak seasons.

Company profile

JIANGXI XIERKANGTAI PHARMACEUTICAL CO., LTD.
Years of Export ExperienceExhibition ExperienceStandardized quality controlFast Delivery
CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs CertifiedExport Year: 21 Years CertifiedNearest Port: Shanghai Port, Guangzhou Port, Ningbo PortAverage Response Time: ≤24h

AI-Powered supplier vetting

SummaryJIANGXI XIERKANGTAI PHARMACEUTICAL CO., LTD. is a China-based manufacturing factory established in 2004, with 126 employees and a combined business entity structure. Its stated scope covers pharmaceutical dosage forms, raw-material production and processing, and exports. The supplier reports customization from samples and designs, documented finished-product inspection, complaint handling, traceability, and quality-assurance procedures. It offers OEM services to well-known brands and has six R&D engineers, but reports no new products during the past year, no ODM service, and no SDK. Export sales account for 90% of total sales, with one-month stated lead times in both peak and off-season periods. Certification details are listed only as “Others,” and no cooperation with Fortune 500 companies is reported. Financial credibility cannot be assessed because the provided information does not include non-financial financial evidence.
Supplier typeThe supplier is identified as a factory and limited company in China, established on January 16, 2004, with 126 employees. Its stated business scope includes pharmaceutical production, processing, and export of raw materials, indicating a manufacturing-oriented supplier rather than a purely trading entity.
After-Sales capabilityThe supplier reports documented and followed procedures for handling customer complaints, service-capability assessment, corrective and preventive actions, and supplier management. However, the stated overseas-service coverage is 0 countries, so the evidence supports internal service processes but not broad overseas after-sales reach.
R&D capabilityThe supplier has six R&D engineers and provides OEM services to well-known brands. However, it reports no new products in the past year, no ODM service, and no available SDK, indicating that documented innovation and independent product-development capability are limited.
Production capacityThe supplier lists multiple pharmaceutical and equipment-related production capabilities, has a stated pharmaceutical manufacturing and processing scope, and reports uniformly followed finished-product inspection instructions. It also reports one-month average lead times in both peak and off-season periods, supporting evidence of established production operations.
Customization capabilityThe supplier explicitly supports customization from samples and from customer designs, and also reports OEM capability for well-known brands. Although it does not provide ODM services, the evidence directly supports customer-led customization and OEM production.

Product Q&A

Q:What is the main indication for Diclofenac Tablet?
A:
It is used for acute and chronic rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, low back pain, sprains, strains, and post-traumatic pain and inflammation.
Q:How should the dosage be administered?
A:
Oral administration is recommended, typically 1 to 2 times a day, or as directed by a doctor.
Q:What are the common adverse reactions?
A:
Common reactions include headache, abdominal pain, gastrointestinal issues like nausea and diarrhea, and occasional dizziness or increased liver enzymes.
Q:Who should avoid taking this medication?
A:
Patients with blood system abnormalities, hypertension, heart disease, severe liver damage, or a history of gastrointestinal ulcers should use it with caution or under strict medical supervision.
Q:Is OEM service available for this product?
A:
Yes, OEM service is available with customization options from both samples and designs.

Send Inquiry

*To:JIANGXI XIERKANGTAI PHARMACEUTICAL CO., LTD.JIANGXI XIERKANGTAI PHARMACEUTICAL CO., LTD.
*Content:
0/4000

Supplier replies will be sent to your registered email

You may also like

High Quality Food Grade Citric Acid Monohydrate
Made-in-China.com
Citric Acid Monohydrate CAS No. 77-92-9
Made-in-China.com
Premium Food Grade Citric Acid Monohydrate E330 Powder
Made-in-China.com
Premium Food-Grade Citric Acid Monohydrate Powder
Made-in-China.com